Women with polycystic ovary syndrome have significantly higher rates of pregnancy loss, as well as elevated insulin and IGF-1 levels. In this study, preimplantation embryos exposed to high concentrations of IGF-1 or insulin undergo extensive apoptosis of the ICM nuclei. Lack of BAX expression, the caspase inhibitor, zVAD, or the ceramide synthase inhibitor, fumonisin B1, prevents this event, suggesting involvement of programmed cell death effector pathways. In other systems, the IGF-1 concentration regulates IGF-1R expression and thus high concentrations lead to down-regulation of the receptor. Here, data show a decrease in IGF-1 receptor protein expression, both by confocal immunofluorescent microscopy and by Western analysis upon exposure to 130 nM IGF-1. Insulin-stimulated glucose uptake, an event regulated via the IGF-1 receptor, is decreased upon exposure to excess IGF-1, suggesting decreased function of the receptor. The data also show that, by blocking receptor signal transduction or by decreasing receptor expression, the apoptotic event can be recreated, thus strongly suggesting that the mechanism of high IGF-1 induced apoptosis is decreased downstream IGF-1 receptor signaling. This embryotoxic insult by high IGF-1 levels may be responsible for the high incidence of pregnancy loss seen in women with polycystic ovary syndrome. (Endocrinology 141: 4784 -4792, 2000) 
W OMEN WITH POLYCYSTIC ovary syndrome exhibit hyperinsulinemia, oligomenorrhea, ovarian morphological changes, and hyperandrogenism. These women also experience significantly higher rates of pregnancy loss (1) (2) (3) . It is not clear whether this effect is due to high androgen levels or elevated gonadotropin levels. Bioactive levels of the insulin-like growth factor, (IGF-1) are also increased in polycystic ovary patients due to an insulin-induced decrease in the production of the binding protein, IGFBP-1 and IGFBP-3 (4 -7). Models of excess IGF-I either in vivo or in vitro demonstrate deleterious effects on the preimplantation embryo (8, 9) . Raising IGF-1 levels either by gonadotropins or by implanting slow release pumps containing IGF-1 adversely affects developmental progression to a blastocyst stage with a larger percentage of degenerated embryos. The blastocysts that do form have smaller numbers of cells. This effect is reversed with anti-IGF-1 antibody infusions or somatostatin analogs. Similarly, elevated in vitro levels of insulin, 600 nm, have been shown to decrease cell number and adversely affect development. Clearly, elevated concentrations of IGF-I or insulin adversely affect the preimplantation embryo and may perhaps be responsible for the increased incidence of fetal loss among women with polycystic ovary syndrome.
The mechanism for these embryotoxic effects of insulin and insulin-like growth factors has not been explored. High insulin concentrations induce loss of the insulin receptor in several different cell types (10, 11) . This phenomenon of hormone-induced receptor loss is dose dependent with a 10 -20% reduction at 10 nm and 60 -85% at 1 m (11). The down-regulation is linear over the first 4 -6 h and then plateaus, where it reaches a new steady-state. As with the insulin receptor, the IGF-1 receptor (IGF-1R) is regulated by the ambient concentration of the IGF-1 ligand (12) . A decrease in receptor number with increasing IGF-1 concentration due to internalization of the complex has been demonstrated in numerous systems, including lymphoid cells, FRTL-5 thyroid cells, endothelial cells, and bovine articular chondrocytes (12, 13) . Similarly, it has been suggested that downregulation occurs in the preimplantation blastocyst (14, 15) .
Insulin and IGF-1 stimulate glucose uptake in the preimplantation blastocyst (16) , and this uptake has been shown to operate via the IGF-1R, not the insulin receptor. Both receptors are first expressed at the 8-cell stage. It is well established in other cell types that the IGF-1R, activated by its ligands, plays a critical role in regulating programmed cell death vs. maintaining the transformed phenotype. Antibodies to the IGF-1R, antisense expression plasmids to IGF-1R, and dominant negative mutants of the IGF-1R can all reverse the transformed phenotype, inhibit tumorigenesis, and result in an increase in apoptosis (17, 18) . De Pablo et al. (19) have also shown that insulin receptor down-regulation by antisense oligonucleotides also leads to increased apoptosis in the neurulating chicken embryo. We propose that similar downregulation of the IGF-1R is occurring in preimplantation embryos exposed to high IGF-1 concentrations leading to significant apoptosis of the inner cell mass (ICM) or key progenitor cells of the embryo. Such an embryotoxic insult may be responsible for the high incidence of pregnancy loss seen in women with polycystic ovary syndrome.
Materials and Methods

Embryo recovery and culture
Embryos were recovered as previously described (20) . In brief, female mice (B6ϫ SJL F1, Jackson Laboratory, Bar Harbor, ME) of 4 -6 weeks of age were given free access to food and water and were maintained on a 12-h light, 12-h dark cycle. Superovulation was achieved with an ip injection of 10 IU/animal of pregnant mare serum gonadotropin (Sigma) followed later by 10 IU/animal of human CG (hCG, Sigma). Female mice were mated with males of proven fertility overnight after hCG injection. Mating was confirmed by identification of a vaginal plug. Animals were killed by cervical dislocation at 48 h after hCG administration and mating. Two-cell and four-cell embryos were obtained by flushing dissected uterine horns and ostia as described previously. The embryos were then immediately placed in Human Tubal Fluid (HTF, Irvine Scientific, CA) containing 0.25% BSA (Sigma, fraction V) and cultured at 37 C in an atmosphere of 5%CO 2 , 5% O 2 and 90% N 2 for 24 h. The experimental conditions included control HTF, HTF with added 1.3 nm or 130 nm IGF-1 (Sigma), 6 nm or 700 nm insulin (Sigma) or 400 nm testosterone. Elevated testosterone levels represent another serum abnormality seen in polycystic ovary syndrome and are thought to have detrimental effects on embryo development.
For the studies in Bax null mice, Bax Ϫ/Ϫ , ϩ/Ϫ, and ϩ/ϩ female mice were superovulated and mated with either Bax ϩ/Ϫ males (for the Bax ϩ/Ϫ and Ϫ/Ϫ females) or Bax ϩ/ϩ males (for the Bax ϩ/ϩ females). BaxϪ/Ϫ males are infertile, and thus Bax heterozygote males must be mated with Bax null females (21) . Embryos were recovered 96 h after mating. For the studies using caspase and ceramide synthase inhibitors, control, wild-type embryos were cultured in high concentrations of IGF-1 with or without either 10 m z-valine-alanine-aspartate-fluoromethylketone, (zVAD-FMK), (BIOMOL Research Laboratories, Inc., Plymouth Meeting, PA), a caspase inhibitor, or 100 m fumonisin B1 (Sigma, St. Louis, MO), a natural, fungal-derived inhibitor of ceramide synthase.
Terminal dUTP nick end labeling (TUNEL) assays to detect apoptosis in blastocysts
This technique has been described previously for mouse blastocysts (22, 23) . Fixed blastocysts were counterstained with propidium iodide to label all nuclear DNA and fragmented DNA was end labeled with fluoroscein isothiocyanate (FITC) labeled dUTP using terminal transferase (Cell Death In situ Kit, Roche Molecular Biochemicals). The embryos were then observed using confocal immunofluorescent microscopy (Bio-Rad Laboratories, Inc. MRC-600). A complete z-series was performed for each blastocyst to ensure that each nucleus was sampled and counted. The degree of apoptosis is expressed as % terminal dUTP nick end labeling (TUNEL)-positive nuclei (green channel) per total nuclei (red channel) per embryo. These experiments were performed in triplicate with 7-10 blastocysts per group for each experiment. This labeling technique was performed on three different test groups, each with a nontreatment control. These groups include 1) blastocysts from Bax Ϫ/Ϫ, ϩ/Ϫ, ϩ/ϩ mice mated as described above and cultured in high vs. low IGF-1; 2) blastocysts cultured in high vs. low IGF-1 with or without added caspase inhibitor, zVAD-FMK; 3) blastocysts cultured in high vs. low IGF-1 with or without added ceramide synthase inhibitor, fumonisin B1.
Expression of IGF-1R protein in response to high ligand concentrations using confocal microscopy
Blastocysts were exposed to 2% Pronase for 2 min, fixed on glass slides with 3% paraformaldehyde, and permeabilized with 0.1% Tween. The embryos were then washed and incubated with a primary chicken antimouse IGF-1R antibody to the ␣Ϫsubunit (Upstate Biotechnology, Inc., Lake Placid, NY) for 1 h at room temperature (10 g/ml). The embryos were then washed and incubated with a secondary antibody, donkey anti-chicken FITC-labeled antibody for 1 h. Nuclear staining was then performed by incubating the embryos in propidium iodide at a concentration of 0.01 mg/ml. Following extensive washing, confocal immunofluorescent microscopy (Bio-Rad Laboratories, Inc. MRC-600, Hercules, CA) was then use to detect fluorescence as previously described (20) . Whole embryo fluorescence was then quantitated using NIH Image (version 1.6).
Expression of IGF-1R protein by Western analysis
Blastocysts were cultured as above and were collected in groups of 20 -30. The pooled samples of equivalent numbers of embryos were then solubilized for 30 min at 4 C in a HEPES buffer (50 mm HEPES, 1 mm EDTA, 150 mm NaCl, 1 mm Vanadate, 1%BSA, 1% Triton, pH 7.4) containing protease inhibitors. The supernatants were then immunoprecipitated overnight with a rabbit polyclonal antimouse IGF-1R antibody directed toward the ␣-subunit and not cross-reactive with the insulin receptor (Upstate Biotechnology, Inc.; 1:1000). Immune complexes were then bound to Protein-A Sepharose beads (Upstate Biotechnology, Inc.) and washed extensively. The samples were then added to 2ϫ sample buffer, subjected to 7.5% SDS-PAGE and transferred to nitrocellulose. IGF-1R was then detected using an antibody generated against the b-subunit of IGF-1R (Santa Cruz Biotechnology, Inc., Santa Cruz, CA; 1:1000).
125 I-Labeled goat antirabbit IgG was used as the secondary antibody. Radioactive bands were quantitated by a PhosphorImager SI Analyzer (Molecular Dynamics, Inc. Sunnyvale, CA). All experiments were performed in triplicate.
Functional analysis of the IGF-1R
Insulin-stimulated glucose transport-an event known to be regulated by the IGF-1R in the mouse blastocyst. Two-cell embryos were cultured for 72 h at 37 C in an atmosphere of 5%CO 2 /5%O 2 /90% N 2 in HTF containing 1.3 nm or 130 nm IGF-1. Embryos were then washed extensively, preincubated for 30 min in HTF without IGF-1 containing 0 or 170 nm insulin. Embryos were directly placed in 200 m 2-deoxyglucose (DG) for 15 min, washed in DG-free, BSA-free buffer for 1 min, and then quick-frozen on a glass slide. After freeze-drying overnight, the embryos were extracted in microliter volumes under oil and single embryos were assayed for DG and 2-deoxyglucose-6-phosphate (DG6P) as described previously (20) . The final measurements are expressed as picomoles per embryo per 15 min. Experiments were performed in triplicate on 10 -15 individual embryos per group for each experiment.
Blocking IGF-1R with blocking antibody ␣IR3
To determine whether blocking IGF-1R signaling would recreate the apoptotic event seen with high IGF-1 concentrations, two cell embryos were cultured for 72 h in 1 g/ml ␣IR3, a monoclonal antibody (Oncogene Research Products, Manhasset, NY) known to inhibit IGF-1 binding in the blastocyst and block activity of the IGF-1R in other cell systems (15) . To confirm that adequate blockade of the receptor was achieved, IGF-1R autophosphorylation and function were measured in blastocysts using Western analysis and DG uptake into single blastocysts as described above. Embryos cultured in ␣IR3 were compared with embryos cultured in high or low concentrations of IGF-1. After demonstration of decreased autophosphorylation and function in these embryos, TUNEL was then used to examine blastocysts exposed to ␣IR3 for evidence of apoptosis. For these experiments, an additional control group of embryos were cultured in an equivalent concentration of an isotypematched IgG1 negative control antibody, trp E (Oncogene Research Products). The TUNEL methods are described above.
Decreasing IGF-1R expression with antisense oligonucleotides
Expression of IGF-1R was blocked with the antisense oligoprobes to determine whether decreased expression of IGF-1R recreates the apoptotic event seen with high IGF-1 concentrations. Two-cell embryos were cultured for 72 h in 0.5 m IGF-1R antisense (5Ј-TCC TCC GGA GCC AGA CTT) or sense (5Ј-AAG TCT GGC TCC GGA GGA) oligodeoxynucleotides corresponding to codons 21-26 of the signal sequence of the ␤Ϫsubunit IGF-1R preceding the proreceptor sequence. These oligodeoxynucleotides have been used previously in rodent models and are known to block expression successfully (17) . Antisense experiments have also been described in a preimplantation embryo system using the protocol outlined here (24, 25) . Four cell embryos were exposed to 0.01% lysolecithin for 30 min and then cultured for a further 48 h in control media containing 5 m IGF-1R sense or antisense. The lysolecithin has been shown to facilitate transfer of the oligonucleotides into the embryos. The embryos were cultured in these conditions in 25 l droplets under oil and were moved to new equivalent droplets after 24 h. The oligodeoxynucleotides used were modified to contain phosphorothioate linkages to decrease degradation. Measuring protein expression and function using confocal immunofluorescent microscopy and 2-DG uptake into individual blastocysts respectively assessed the efficiency of the antisense treatment. After demonstration of decreased IGF-1R expression and function in these embryos, TUNEL was then used to examine blastocysts for evidence of apoptosis. These methods are also described above.
Statistical methods
Differences between the groups with protein expression, insulinstimulated glucose uptake and percent TUNEL staining were compared by one-way ANOVA coupled with Fisher test (Statview 4.5). Differences between the blastocysts from the different BAX genotypes exposed to high or low concentrations of IGF-1 also were compared by ANOVA coupled with Fisher test. Results are expressed as means Ϯ se of at least three separate experiments.
Results
Measurement of physiological levels of IGF-1 and insulin in primate fallopian tubes
To test whether the in vitro IGF-1 concentrations chosen accurately represented high but physiologic relevant levels, we measured intrafallopian tube IGF-1 concentrations in humans and nonhuman primates. The two human subjects were 35-to 37-yr-old women undergoing tubal ligations. The nonhuman primate samples were collected from cannulated rhesus monkeys that had been oophorectomized and replaced with either estrogen alone or estrogen and progesterone (a generous gift from Dr. Harold Verhage, University of Illinois at Chicago). IGF-1 levels were measured by RIA by the Washington University School of Medicine Diabetes Research and Training Center Core Laboratory. The values measured were 429 and 479 ng/ml for the human samples and 404 and 474 ng/ml, and 138 and 378 ng/ml for the rhesus monkeys receiving estrogen and progesterone or estrogen alone, respectively. Intrafallopian tube insulin levels were Ͻ2 U/ml. Although it is not clear why IGF-1 levels would be lower in monkeys given estrogen vs. estrogen and progesterone, it is impossible to draw any conclusions about this difference due to the small sample size. However, it is apparent from these values for control subjects, that the in vitro concentration of 950 ng/ml or 130 nm IGF-1 does represent a high physiologic concentration. The only other human study that measured intrafallopian tube IGF-1 levels, however, reported levels in the range of 4 -10 ng/ml (26). It is not clear why there is a discrepancy between our findings and these studies. Our human subjects were post partum, and this condition may explain the high levels. The monkeys were receiving exogenous sex steroids, and this may also elevate levels. Regardless of the differences, we determined that in a physiologic, non-PCOS state IGF-1 levels range from 4 -480 ng/ml, confirming that the in vitro levels we chose to represent low, mid-level, and high were physiologically appropriate.
IGF-1 induces apoptosis in mouse blastocysts
Apoptotic cell assays revealed significantly elevated % TUNEL-positive or % nuclei containing fragmented DNA/ total nuclei in blastocysts exposed to 130 nm IGF-1 (n ϭ 17) vs. 1.3 nm (n ϭ 16); 63 Ϯ 9% vs. 6 Ϯ 2%, respectively (P Ͻ 0.001) (Fig. 1) . There was no significant difference between embryos cultured in low IGF-1 vs. control medium, and thus this lower concentration was used as a control for the remaining experiments. The DNA fragmentation detected occurred predominantly in the ICM nuclei. Similarly, high insulin also caused an increase in DNA fragmentation with 70 Ϯ 9.9% apoptotic nuclei in embryos cultured in 700 nm insulin (n ϭ 15) compared with 7 Ϯ 3.1% in 6 nm insulin (n ϭ 20) (P Ͻ 0.001). In contrast, high concentrations of testosterone (400 nm) failed to induce increased DNA fragmentation.
Next, preliminary studies were performed to determine whether this event was dose dependent. Two cell embryos were incubated for 72 h in intermediate doses of insulin (350 nm) and IGF-1 (65 nm) and examined for evidence of apoptosis as described above. Using these conditions, apoptotic rates were approximately 50% of those seen for high and low insulin and IGF-1 (data not shown). Embryos incubated in an intermediate concentration of insulin and IGF-1 displayed 34 Ϯ 8% (n ϭ 10) and 36 Ϯ 5% (n ϭ 7) TUNEL-positive nuclei per total nuclei per embryo, respectively. This intermediate apoptotic event is consistent with a dose dependency of this IGF-1 induced apoptosis. These findings suggest an EC 50 for this effect of approximately 65 nm for IGF-1 and 350 nm for insulin. This concentration is close to the EC 50 noted for insulin receptor down regulation by insulin. Because IGF-1 is more potent in regards to this bioactivity, it is assumed that IGF-1 is acting via the IGF-1R.
IGF-1-induced apoptosis is BAX-dependent and involves caspases and ceramide synthesis
To test whether activation of the BAX cell-death effector system is involved in IGF-induced apoptosis, as is seen in hyperglycemia-induced apoptosis (23), two cell embryos from matings of Bax Ϫ/Ϫ females with Bax ϩ/Ϫ males were cultured for 72 h in HTF containing 1.3 nm (n ϭ 17) or 130 nm IGF-1 (n ϭ 19). These results were compared with embryos from Bax ϩ/ϩ females mated with Bax ϩ/ϩ males (n ϭ 15 low IGF-1 and n ϭ 17 high IGF-1). BaxϪ/Ϫ males are infertile (21) and thus Bax heterozygote males must be mated with Bax null females. Consistent with the predicted 50% null embryo mendelian ratio, half the embryos obtained from the Bax ϩ/Ϫ X BaxϪ/Ϫ matings showed almost complete resistance to IGF-1-induced apoptosis, 5 Ϯ 3% in High IGF-1 (n ϭ 10) vs. 6 Ϯ 4% in low IGF-1 (n ϭ 14) TUNEL-positive nuclei (Fig. 2) . The other half exhibited an apoptotic phenotype similar to the control wild-type embryos. These results were in comparison to 64 Ϯ 7% and 7 Ϯ 3% among the embryos from Bax ϩ/ϩ matings. These in vitro findings are consistent with an important role for BAX in high IGF-1-induced embryo cell death.
To examine the role of caspases in glucose-induced embryotoxicity, control two-cell embryos were pretreated for 1 h in 10 m zVAD-FMK, the cell-permeable tri-peptide inhibitor of caspase-1,-3, and -8 (27) (28) (29) . Inhibition of this caspase significantly lowered the apoptotic response to high IGF-1 in these blastocysts (Fig. 3) with only 21 Ϯ 7% TUNELpositive nuclei per embryo (n ϭ 22) vs. 57 Ϯ 9% in control embryos incubated in high IGF-1 alone (n ϭ 23). Results were similar in high and low insulin (data not shown). Despite some findings suggesting a caspase-independent BAXinduced cell death pathway (30) , these results combined with the BaxϪ/Ϫ embryo findings support the hypothesis of a hierarchical cell death pathway system with caspases acting downstream of BAX (31) .
Preincubating 2-cell embryos with 100 m fumonisin B1, a fungal toxin that specifically inhibits ceramide synthase (32), maintained cell survival and prevented the apoptotic event caused by a high concentration of IGF-1 (See Fig. 3, A  and B) . Only 23 Ϯ 4% TUNEL-positive nuclei per embryo were seen among the embryos in fumonisin B1 (n ϭ 19) vs. 57 Ϯ 9% in control embryos incubated in high IGF-1 alone (n ϭ 20). Although this fungal toxin recently has been shown to have no preventative effect on mouse oocytes undergoing daunorubicin-induced ceramide-related apoptosis (33), we have shown that inhibition of ceramide synthase in the mouse blastocyst partially prevents high glucose induced apoptosis. Similarly, ceramide synthase inhibition has been shown in several other cell types to inhibit stress-activated apoptosis (34) . Clearly these findings provide evidence that generation of ceramide contributes to the high IGF-1-induced apoptotic signaling pathways in the mouse blastocyst. 
High IGF-1 induced decrease in IGF-1R expression
Evidence provided by prior studies of both the IGF-1 and insulin receptors has suggested that high IGF-1 concentrations trigger apoptosis by a down-regulation of the IGF-1R (17, 18) . To test the hypothesis, immunofluorescent confocal microscopy was used to detect protein expression of the IGF-1R. With this technique, 53 Ϯ 2% less IGF-1R protein was detected in the embryos exposed to high IGF-1(n ϭ 7) vs. embryos in low IGF-1 (n ϭ 9) (Fig. 4A) . A similar decrease in IGF-1R protein expression was seen when immunoprecipitation combined with Western blot analysis on groups of pooled embryos was used. Blastocysts were cultured as above except that three different concentrations of IGF-1, 1.3, 65, 130 nm, were used to determine whether this downregulation was dose dependent. This experiment was performed twice with 40 -60 blastocyst per group. By Western analysis, a 45 Ϯ 9% reduction in IGF-1R protein was seen among embryos exposed to high IGF-1 levels in vitro vs. low IGF-1, and this decline in protein expression was dose dependent (Fig. 4B) .
High IGF-1 induced decrease in IGF-1R regulated insulinstimulated glucose uptake into the mouse blastocyst
Studies have recently demonstrated that IGF-1 and insulin regulate glucose transport in mouse blastocysts. Dose response and antiinsulin receptor antiserum studies revealed that stimulation occurs via the IGF-1R and not the insulin receptor (35) . IGF-1 stimulated transport half maximally at 1.0 pm, a value well within the range for normal physiologic stimulation of the IGF-1R. In contrast, a 1,000-fold higher level of insulin was required to see the same effect. Thus, insulin stimulated this transport event by cross-reaction with IGF-1R. Experiments using the specific agonistic insulin receptor antibody, B10, confirmed that the insulin receptor was not involved in glucose uptake because exposure to B10 did not affect glucose uptake in the blastocyst. Similarly, in Xenopus oocytes, insulin stimulated glucose uptake is also mediated by IGF-1 (36) .
The next hypothesis to test was that this glucose transport event was down-regulated in response to high IGF-1 as is insulin-stimulated glucose transport in most other systems in response to high insulin. Using these techniques, a significant 80-fold reduction in the insulin-stimulated DG uptake was   FIG. 4 . High concentrations of IGF-1 decrease protein expression of the IGF-1R. A, Blastocysts cultured from a 2-cell stage in either 1.3 nM or 130 nM IGF-1 were fixed and stained with propidium iodide (red channel) and IGF-1R polyclonal 1 degree antibody with an FITClabeled 2 degree antibody (green channel) and visualized by confocal immunofluorescent microscopy. A significant decrease in protein expression was seen among those embryo cultured in the higher concentration. B, Blastocysts cultured under the same conditions as in A. were subjected to 7.5% SDS-PAGE. Each sample represents 40 -60 embryos. A dose-dependent decrease in protein expression was seen.
FIG. 5.
High concentrations of IGF-1 decrease insulin-stimulated glucose transport into the blastocyst. 2-Deoxyglucose uptake in blastocysts exposed to the control conditions of 1.3 nM IGF-1, 130 nM IGF-1, 700 nM insulin and 400 nM testosterone. High concentrations of IGF-1 or insulin result in a significant decrease in insulin-stimulated glucose uptake as measured by 2-deoxyglucose uptake. Significance between control and IGF-1, *P Ͻ 0.001, between control and insulin, **P Ͻ 0.01. measured in embryos exposed to high IGF-1 (basal, n ϭ 21; insulin-stimulated, n ϭ 22) compared with control embryos stimulated with insulin (*, P Ͻ 0.001, basal, n ϭ 25; insulinstimulated, n ϭ 20, Fig. 5 ). High insulin exposure for 72 h followed by insulin-stimulated glucose uptake assay resulted in a 1.6-fold reduction basal, n ϭ 15; insulin-stimulated, n ϭ 12), which likewise was significant (**, P Ͻ 0.01). In contrast, elevated testosterone concentrations had no effect on insulin-stimulated glucose transport (basal, n ϭ 12, insulin-stimulated n ϭ 11) (37) .
IGF-1R blockade with ␣IR3 decreases receptor autophosphorylation and insulin-stimulated glucose uptake and triggers apoptosis
To confirm that the effect of high IGF-1 on down-regulation of the receptor is responsible for the apoptotic event, an inhibitor of IGF-1 binding to its receptor was used. ␣IR3 blockade of the receptor successfully inhibited IGF-1R autophosphorylation upon addition of insulin (Fig. 6A) . Likewise, ␣IR3 treatment resulted in inhibition of insulinstimulated glucose uptake at a blastocyst stage (Fig. 6B) . Having confirmed that the blockade worked, apoptosis was examined using TUNEL. Microscopy revealed increased % TUNEL-positive nuclei in the embryos exposed to ␣IR3 (46 Ϯ 9; n ϭ 20) compared with embryos cultured in 1.3 nm IGF-1 (6.0 Ϯ 3; n ϭ 21) and a similar % apoptotic nuclei compared with embryos cultured in 130 nm IGF-1 (63 Ϯ 9; n ϭ 22) (Fig.  6C ). This provides further evidence that a decrease in signaling via the IGF-1R is responsible for the apoptotic event.
Antisense oligonucleotide exposure decreases protein expression and glucose transport and triggers apoptosis
To further test the hypothesis that decreased expression of the receptor is responsible for the apoptosis, antisense vs. sense oligoprobes were used. Immunofluorescent confocal microscopy confirmed a decrease in protein expression in response to antisense (Fig. 7A ). This decrease in expression correlated with a decrease in insulin-stimulated DG uptake (Fig. 7B ). This decrease in protein expression and function lead to an increase in TUNEL-positive nuclei in the embryos cultured in antisense (35 Ϯ 8; n ϭ 27). This increase was significantly greater than embryos cultured in sense (5 Ϯ 3;n ϭ 22) or embryos in 1.3 nm IGF-1 (6 Ϯ 4; n ϭ 16) and was similar to embryos cultured in 130 nm IGF-1 (63 Ϯ 10; n ϭ 15) (Fig. 7C ).
Discussion
In this study, we demonstrate that embryos exposed to high concentrations of IGF-1 or insulin undergo extensive apoptosis of the mouse blastocyst nuclei. Lack of BAX expression, the caspase inhibitor, zVAD, or the ceramide synthase inhibitor, fumonisin B1, prevents this event, suggesting involvement of programmed cell death effector pathways. In   FIG. 6 . IGF-1R blockade with ␣IR3 decreases insulin-stimulated autophosphorylation of the receptor and glucose uptake and triggers apoptosis. Embryos cultured in 1 g/ml ␣IR3 were examined for effects on receptor signaling. A, Receptor autophosphorylation was measured by immunoprecipitation with anti-IGF-1R followed by immunoblotting with anti-PY20 using embryos stimulated with insulin. A significant decrease in receptor autophosphorylation was seen. B, Individual embryos cultured in 1.3 nM IGF-1, 130 nM IGF-1, or 1 g/ml ␣IR3 were assayed for deoxyglucose (DG) uptake as described above. Embryos cultured in ␣IR3 demonstrated a significant decrease insulin-stimulated DG uptake compared with control. This decrease was similar to that seen among embryos exposed to elevated IGF-1 conditions. C, Embryos cultured in a) 1.3 nM IGF-1, b) 130 nM IGF-1, c) 1 g/ml ␣IR3 or d) 1 g/ml trp E (negative control) were examined for TUNEL-positive staining. Note that ␣IR3 exposure resulted in a significant increase in TUNEL-positive nuclei.
other systems, the IGF-1 concentration regulates IGF-1R expression and thus high concentrations lead to down-regulation of the receptor. In addition, exposure to 130 nm IGF-1 results in a decrease in IGF-1R protein expression in the mouse blastocyst, both by confocal immunofluorescent microscopy and by Western analysis. In this embryo system, the data suggest that decreased signaling via the IGF-1R may be responsible for the apoptosis seen. Specifically, downstream insulin-stimulated glucose uptake is decreased upon exposure to excess IGF-1. Finally, blockade of receptor signal transduction or a decrease in receptor expression recreated the apoptotic event, thus strongly suggesting that the mechanism of high IGF-1 induced apoptosis is decreased IGF-1R signaling.
Apoptosis in the rodent and human preimplantation embryo is a normal process (38 -40) . Regulation of this apoptotic process is essential for future development of the embryo. Programmed cell death at this stage of mammalian development is thought to eliminate redundant cells in the inner cell mass, which retain trophectoderm potential after differentiation and thus are deficient in normal developmental capacity (41) . In human embryos obtained for in vitro fertilization, apoptosis occurs in normal appearing embryos but is much more prevalent in arrested and fragmented embryos, which are often not used for transfer due to their morphology (38, 42) . Studies have also shown increased cell death in mouse preimplantation embryos undergoing retarded, suboptimal development. Suggestions have been made that uncontrolled apoptosis or programmed cell death occurring earlier than a blastocyst stage in preimplantation embryos may lead to embryo demise (38) . We have previously shown that high glucose-induced apoptosis causing increased apoptosis at a blastocyst stage results in higher resorption rates in a mouse model. Therefore, up-regulation of the apoptotic pathway may protect the early embryo by eliminating abnormal cells; however, loss of balance in this tissue remodeling may lead to developmental arrest and demise.
Lack of a threshold level of glucose transport triggers apoptosis in the blastocyst (24) . This phenomenon occurs in maternal hyperglycemia. In earlier studies, we have demonstrated that hyperglycemia leads to down-regulation of the GLUTS at the blastocyst stage in response to hyperglycemia (20) . This occurs concurrently with the onset of increased apoptotic nuclei (23) . Blocking GLUT1 expression during the first 72 h in culture with antisense oligonucleotides results in increased apoptosis in the blastocyst stage (24) . Similarly, in other cells systems, decreased basal glucose uptake has been shown to initiate the programmed cell death cascade (43-45) whereas overexpression of GLUT1 can protect against apoptosis (46) . The clinical manifestation of this preimplantation event in mice is increased pregnancy loss and congenital malformations, both occurring at a greater frequency in maternal hyperglycemia due to insulin-dependent diabetes mellitus. It should be noted that decrease glucose transport and apoptosis are not the only explanation for the increased pregnancy loss and fetal anomalies among these patients. Several studies using postimplantation models of diabetic embryopathies have implicated other diabetesassociated metabolic alterations. These include increased generation of oxygen free radicals (47) , increased sorbitol and ␤-hydroxybutyrate (48 -50), and decreased myoinositol levels (51) . At the blastocyst stage, embryonic metabolism switches from using oxidative phosphorylation of pyruvate to glycolysis of glucose (52) . This energy switch is believed to occur in preparation for implantation and a temporary anaerobic existence and to afford synthesis of macromolecules from glycolytic intermediates (53, 54) . As a result, glucose consumption increases significantly, with the greatest consumption occurring in the inner cell mass (55) . Simultaneous to this increase in glucose consumption, the blastocyst exits from the fallopian tube and enters the uterine cavity, at which time in normal physiology insulin and IGF-1 levels both rise (26) . It is believed that an insulin/IGF-1 regulated glucose transporter, specifically GLUT8, which we have recently cloned from a blastocyst complementary DNA library (56) , responds by translocating to the apical plasma membranes of the blastocyst to maintain glucose homeostasis despite this major shift in energy consumption and glucose utilization. We speculate that with hyperinsulinemia or high IGF-1 levels, the IGF-1/IGFR signaling mechanisms necessary to traffic GLUT8 to the plasma membrane are dysfunctioning, and that without this critical increase in glucose uptake by GLUT8, the lower threshold of glucose is reached and programmed cell death is triggered. This hypothesis agrees with the finding that the TUNEL-positive nuclei are predominantly in the ICM, which at this stage has the greatest demand for glucose consumption. If the degree of programmed cell death is significant enough within the ICM, the pregnancy may result in a fetal resorption.
Women with polycystic ovary syndrome have significantly higher rates of spontaneous miscarriages (1-3). Hyperinsulinemia in these women is associated with elevated bioactive levels of IGF-1 in serum, follicular fluid and presumably fallopian tube fluid. Elevated concentrations of this growth factor are known to adversely affect embryo development both in vivo and in vitro (8, 9) . This study suggests that apoptosis is triggered and accelerated in the mouse blastocyst as a result of IGF-1-induced down-regulation of the receptor and subsequent decreased signaling of IGF-1R associated pathways. Decreased insulin stimulated glucose uptake via GLUT8 may be the inciting metabolic event to trigger apoptosis. This IGF-1-induced embryotoxic insult may be responsible for the high incidence of pregnancy loss seen in women with polycystic ovary syndrome. Given this information, attempts should be made to lower IGF-1 levels by lowering insulin levels in these women to decrease their miscarriage rate.
